Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Fagonia arabica is traditionally used in Middle Eastern and South Asian medicine for treating fever, infections, and blood purification. In Unani and Ayurvedic traditions, it is employed as an antipyretic and general tonic. Folk use includes cancer support, though this application lacks robust clinical evidence. The herb's antimicrobial and anti-inflammatory properties have been noted in preliminary studies. Evidence level: C (traditional use with limited clinical validation).
How does Fagonia arabica work in the body?
Fagonia arabica contains bioactive compounds including fagoniamide, flavonoids, saponins, tannins, and alkaloids that contribute to its medicinal properties. These compounds exhibit antioxidant, anti-inflammatory, and antipyretic activities through modulation of inflammatory pathways. The flavonoids and alkaloids may help reduce oxidative stress and support immune function. Traditional use suggests blood purification effects, though exact mechanisms require further research. Evidence level: C (preliminary studies).
What is the recommended dosage of Fagonia arabica?
The traditional adult dosage for Fagonia arabica is 5-10 grams of dried herb prepared as a tea, taken twice daily. This preparation is commonly used in Unani and Ayurvedic medicine for fever and general health support. Dosage may vary based on individual factors and the specific condition being addressed. Standardized clinical dosing guidelines are not established, so practitioner guidance is recommended. Evidence level: Traditional use.
Is Fagonia arabica safe to take during pregnancy?
Fagonia arabica is considered unsafe during pregnancy and should be avoided. Traditional use and preliminary research suggest it may affect uterine function and blood composition, posing potential risks to fetal development. Women who are pregnant, planning to become pregnant, or breastfeeding should not use this herb. Consult a qualified healthcare provider for safe alternatives during pregnancy. Evidence level: C (traditional contraindication).
Does Fagonia arabica interact with any medications?
There is limited clinical data on drug interactions with Fagonia arabica. Due to its bioactive compounds, it may theoretically interact with anticoagulant medications, immunosuppressants, or drugs metabolized by the liver. The herb's traditional use for blood purification suggests potential interactions with blood-thinning medications. Patients taking prescription medications should consult a healthcare provider before use. Evidence level: C (theoretical based on constituent profile).
What are the side effects of Fagonia arabica?
Reported side effects of Fagonia arabica are primarily mild gastrointestinal upset, including nausea and stomach discomfort. These effects are typically associated with higher doses or sensitive individuals. Due to limited safety studies, the full profile of adverse effects is not well documented. Discontinue use if digestive symptoms persist and consult a healthcare provider if side effects worsen. Evidence level: C (traditional use reports).
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 24 articles PubMed · modèle : gemma4:31b
Résumé
Fagonia arabica is a medicinal plant from the Zygophyllaceae family found in desert regions, recognized for its thrombolytic, antioxidant, and antimicrobial properties [PMID:34554901, PMID:40751117].
Contexte
Fagonia arabica (also known as Dhamasa) is a medicinal plant widely distributed in desert areas including Saudi Arabia, Pakistan, India, South Africa, and Egypt [PMID:34554901, PMID:40751117].
Usages traditionnels
It is traditionally used in Ayurvedic and Unani medicine as a natural blood purifier to aid in dissolving blood clots and reducing the risk of cardiovascular events and brain hemorrhage [PMID:41306891]. Other traditional uses include treating sore mouth, smallpox, vertigo, stomatitis, and conditions related to hematological, neurological, endocrinological, and inflammatory systems [PMID:34554901]. It is also used as a folk remedy for anti-inflammatory, analgesic, and antipyretic effects [PMID:19520135, PMID:24250453].
Composés actifs
The plant contains a wide range of bioactive constituents including saponins (specifically triterpenoid saponins), flavonoids, glycosides, tannins, steroids, terpenoids, diterpenes, phenols, alkaloids, and phenolic compounds such as chlorogenic acid, gallic acid, and catechin [PMID:34554901, PMID:40751117, PMID:8728716, PMID:17338564, PMID:39939326].
Mécanisme d'action
Fagonia arabica demonstrates thrombolytic activity by antagonizing thrombin-induced release of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in human umbilical vein endothelial cells [PMID:27419084]. It also exhibits antioxidant activity by scavenging free radicals (ABTS.+) and modulating cellular antioxidant enzymes such as SOD, CAT, GSH-Px, and GSH-R [PMID:19520135, PMID:24250453].
Preuves cliniques
Preuve DThrombosis/Blood Clots
In vitro studies show significant clot lytic potential, with some extracts showing patterns similar to streptokinase [PMID:21427565, PMID:17986325, PMID:27833372].
Preuve DCoagulation
Aqueous extracts demonstrate potent anticoagulant activity, with some fractions showing significant results compared to heparin [PMID:23814169].
Preuve DBacterial Infections
Extracts showed significant inhibitory actions against Staphylococcus epidermidis and other bacterial strains [PMID:40751117, PMID:37533430].
Preuve DMale and Female Fertility
Ethanol extracts of aerial parts were found to enhance fertility in both male and female Wistar rats [PMID:35642406].
Preuve DCancer
Extracts showed anti-proliferative activity against HeLa and HepG2 cell lines in vitro [PMID:39764423].
Preuve DGastric Diseases (H. pylori)
F. arabica exhibited significant anti-urease inhibitory activity [PMID:40089925].
Sécurité et effets indésirables
Acute oral toxicity tests were performed as part of a polyherbal antidiabetic formulation, though specific adverse effects for F. arabica alone are not detailed in the provided abstracts [PMID:40679012].
Synthèse des preuves
The current evidence is primarily based on in vitro studies, animal models (rats/mice), and literature reviews. There is a lack of human clinical trials (RCTs) to establish clinical efficacy and safety in humans.
Sources PubMed
1.PMID: 34554901 (2022) — Fagonia arabica L.: A Review of its Phytochemistry, Pharmacology and Traditional Uses. · Combinatorial chemistry & high throughput screening
2.PMID: 17986325 (2007) — Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis. · BMC complementary and alternative medicine
3.PMID: 27833372 (2015) — In vitro thrombolytic activity of Dhamasa (Fagonia arabica Linn.), Kushta (Saussurea lappa Decne.), and Guduchi (Tinospora cordifolia Thunb.). · Ayu
4.PMID: 41306891 (2025) — Liposomal formulation of Fagonia arabica L. enhances antithrombotic efficacy: phytochemical, pharmacological, and computational investigations. · RSC advances
5.PMID: 40751117 (2025) — Insight into the biological activities of Fagonia Arabica L. and its phytochemical constituents.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
6.PMID: 8728716 (1996) — Saponins from Fagonia arabica. · Phytochemistry
7.PMID: 17338564 (2007) — Sulfated triterpene derivatives from Fagonia arabica. · Journal of natural products
8.PMID: 39764423 (2025) — Growth suppressing effect of Fagonia arabica extracts on cancerous cell line. · Cytotechnology
9.PMID: 24250453 (2012) — Antioxidant Potential of Fagonia arabica against the Chemical Ischemia-Induced in PC12 Cells. · Iranian journal of pharmaceutical research : IJPR
10.PMID: 39939326 (2025) — UPLC-qTOF-MS/MS profiling of phenolic compounds in Fagonia arabica L. and evaluation of their cholinesterase inhibition potential through in-vitro and in-silico approaches. · Scientific reports
11.PMID: 21427565 (2011) — In-vitro clot lytic potential of Fagonia arabica: a comparative study of two methods. · Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
12.PMID: 18069237 (2007) — Phytochemical and molluscicidal investigations of Fagonia arabica. · Zeitschrift fur Naturforschung. C, Journal of biosciences
13.PMID: 37533430 (2023) — Antibacterial Activity of Economically Important Medicinal Plants in Pakistan Against Different Bacterial Strains. · Bioinformatics and biology insights
14.PMID: 35642406 (2022) — Phytochemical analysis and fertility enhancement effects of aerial parts of Fagonia arabica in male and female rats. · Pakistan journal of pharmaceutical sciences
15.PMID: 23814169 (2014) — Effect of aqueous extract and fractions of Fagonia arabica on in vitro anticoagulant activity. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
16.PMID: 27419084 (2016) — Effect of Fagonia arabica on thrombin induced release of t-PA and complex of PAI-1 tPA in cultured HUVE cells. · Journal of traditional and complementary medicine
17.PMID: 40679012 (2025) — Formulation and evaluation of safe and effective polyherbal antidiabetic drug. · Pakistan journal of pharmaceutical sciences
18.PMID: 19520135 (2009) — Protection of PC12 cells from chemical ischemia induced oxidative stress by Fagonia arabica. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
19.PMID: 40089925 (2025) — In vitro urease inhibition screening of some edible and medicinal herbs to combat Helicobacter pylori related gastric diseases. · Pakistan journal of pharmaceutical sciences
20.PMID: 21814440 (2010) — Synergistic activity of Fagonia arabica and Heteropneustes fossilis extracts against myocardial, cerebral infarction, and embolism disorder in mice. · Journal of pharmacy & bioallied sciences